22.82USD-6.21%Mkt Cap: —P/E: 256.401d ago
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery sy…
Industry Peers
Health Information Services$38.07BUSDP/E 44.2
$40.77BUSDP/E 44.6
$11.74BUSDP/E 53.0
$11.05BUSD
$8.71BUSDP/E 38.9
$8.10BUSD
$7.14BUSDP/E 10.8
$4.76BUSDP/E 35.5
$4.62BUSDP/E 30.9
$3.96BUSD
$2.75BUSDP/E 97.7
$1.66BUSDP/E 43.4
$1.50BUSDP/E 36.5
$1.48BUSD
$1.28BUSD
$1.21BUSDP/E 59.0
$1.18BUSD
$870.57MUSD
$834.80MUSDP/E 39.7
$738.82MUSDP/E 74.8
Key Statistics
Company
Market Cap—
Enterprise Value1.89B $
Revenue (TTM)1.04B $
Gross Profit583.32M $
Net Income (TTM)-63.31M $
Revenue/Share15.25 USD
Last Price22.82 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISINUS8753722037
Valuation
P/E (Trailing)256.40
P/E (Forward)—
PEG—
EV/EBITDA-75.38
EV/Revenue1.81
P/S—
P/B12.33
EPS (TTM)0.09
EPS (Forward)—
52W Range
21.5242% of range24.65
52W High24.65 USD
52W Low21.52 USD
Profitability
Gross Margin56.01%
Oper. Margin-5.42%
EBITDA Margin-2.40%
Profit Margin-6.08%
ROE-48.03%
ROA-2.65%
Growth
Revenue Growth5.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.52M $
CapEx (TTM)—
FCF Margin-4.22%
FCF Yield—
Net Debt283.26M $
Net Debt/EBITDA-11.32
Balance Sheet
Debt/Equity566.96
Current Ratio3.18
Quick Ratio2.44
Book Value/Sh1.875 USD
Cash/Share6.554 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.57.37M
Float63.59M
Insiders1.15%
Institutions115.72%
Technical
SMA 5025.84 (-11.7%)
SMA 20025.68 (-11.1%)
Beta1.54
S&P 52W Chg20.80%
Avg Vol (30d)571
Avg Vol (10d)877
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—